0.6968
price up icon1.56%   0.0107
 
loading
前日終値:
$0.6861
開ける:
$0.69
24時間の取引高:
373.46K
Relative Volume:
2.96
時価総額:
$67.06M
収益:
$775.30K
当期純損益:
$-35.32M
株価収益率:
-1.2443
EPS:
-0.56
ネットキャッシュフロー:
$-19.15M
1週間 パフォーマンス:
-13.98%
1か月 パフォーマンス:
+0.21%
6か月 パフォーマンス:
-4.23%
1年 パフォーマンス:
-9.27%
1日の値動き範囲:
Value
$0.62
$0.73
1週間の範囲:
Value
$0.62
$0.84
52週間の値動き範囲:
Value
$0.4301
$1.23

VolitionRX Ltd Stock (VNRX) Company Profile

Name
名前
VolitionRX Ltd
Name
セクター
Healthcare (1200)
Name
電話
646 650 1351
Name
住所
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
職員
37
Name
Twitter
@VolitionRx
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
VNRX's Discussions on Twitter

VNRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
VNRX
VolitionRX Ltd
0.6968 67.06M 775.30K -35.32M -19.15M -0.56
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-02-01 ダウングレード The Benchmark Company Buy → Hold
2022-02-17 再開されました Cantor Fitzgerald Overweight
2021-03-10 開始されました Cantor Fitzgerald Overweight
2018-05-16 開始されました Maxim Group Buy
2018-05-14 繰り返されました The Benchmark Company Buy
2016-09-07 繰り返されました Rodman & Renshaw Buy
2016-02-01 開始されました Rodman & Renshaw Buy
すべてを表示

VolitionRX Ltd (VNRX) 最新ニュース

pulisher
Nov 23, 2024

Benchmark Reaffirms Hold Rating for VolitionRx (NYSE:VNRX) - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

VolitionRx (NYSE:VNRX) Coverage Initiated at StockNews.com - Defense World

Nov 22, 2024
pulisher
Nov 20, 2024

VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024
pulisher
Nov 16, 2024

VolitionRx Limited (AMEX:VNRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 16, 2024
pulisher
Nov 16, 2024

VolitionRX: Q3 Earnings Snapshot - New Haven Register

Nov 16, 2024
pulisher
Nov 16, 2024

VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

VolitionRx Posts Strong Q3 Growth and Strategic Advances - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Lagoda Investment Management's Strategic Acquisition in Volition - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Armistice Capital, LLC Acquires New Stake in VolitionRX Ltd - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

VolitionRX Ltd Reports Q3 Revenue of $475,000, Missing Estimates of $0.65 Million - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to L - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - MarketBeat

Nov 12, 2024
pulisher
Nov 08, 2024

VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update - Yahoo Finance

Nov 08, 2024
pulisher
Nov 06, 2024

Volition Appoints Timothy I. Still as Chairman – Company Announcement - Financial Times

Nov 06, 2024
pulisher
Nov 04, 2024

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World

Nov 04, 2024
pulisher
Oct 31, 2024

Abionic’s test enters increasingly competitive sepsis fray - BioWorld Online

Oct 31, 2024
pulisher
Oct 27, 2024

VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024
pulisher
Oct 09, 2024

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow

Oct 09, 2024
pulisher
Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow

Sep 30, 2024
pulisher
Sep 30, 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director – Company Announcement - Financial Times

Sep 30, 2024
pulisher
Sep 27, 2024

VolitionRx announces executive employment updates - Investing.com India

Sep 27, 2024
pulisher
Sep 18, 2024

Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY

Sep 18, 2024
pulisher
Sep 18, 2024

Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times

Sep 18, 2024
pulisher
Sep 18, 2024

Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend

Sep 18, 2024
pulisher
Sep 18, 2024

Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week

Sep 18, 2024
pulisher
Sep 18, 2024

Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse

Sep 18, 2024
pulisher
Sep 17, 2024

Volato Facing Class-action WARN Act Lawsuit - Aviation International News

Sep 17, 2024
pulisher
Sep 17, 2024

VolitionRx offers oncology assets for licensing - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 16, 2024

Volition Announces Board of Directors - TechBuzz News

Sep 16, 2024
pulisher
Sep 14, 2024

CRYPTOPSY's New Shirts Are Very Serious - Metal Injection

Sep 14, 2024
pulisher
Sep 13, 2024

Terminated Volato Employees File Class Action Lawsuit - FLYING

Sep 13, 2024
pulisher
Sep 12, 2024

LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24

Sep 12, 2024
pulisher
Sep 11, 2024

Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance

Sep 11, 2024
pulisher
Sep 05, 2024

VolitionRX Ltd [VNRX] Records 200-Day SMA of $0.7821 - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

The Potential Rise in the Price of VolitionRX Ltd (VNRX) following insiders activity - Knox Daily

Sep 02, 2024
pulisher
Aug 29, 2024

VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million fi - Yahoo Finance

Aug 29, 2024
pulisher
Aug 28, 2024

Understanding the Risks of Investing in VolitionRX Ltd (VNRX) - Knox Daily

Aug 28, 2024
pulisher
Aug 27, 2024

Comparing OncoCyte (NASDAQ:OCX) & VolitionRx (NYSE:VNRX) - Defense World

Aug 27, 2024
pulisher
Aug 24, 2024

VolitionRx (NYSEAMERICAN:VNRX) Stock Price Passes Above 50-Day Moving Average of $0.00 - Defense World

Aug 24, 2024
pulisher
Aug 22, 2024

VolitionRx Limited (NYSE:VNRX) Director Guy Archibald Innes Purchases 150,000 Shares - Defense World

Aug 22, 2024
pulisher
Aug 18, 2024

VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlight - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

Benchmark Reiterates Hold Rating for VolitionRx (NYSE:VNRX) - Defense World

Aug 18, 2024
pulisher
Aug 17, 2024

VolitionRx Limited (AMEX:VNRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 17, 2024
pulisher
Aug 16, 2024

Earnings call: VolitionRx reports strong growth and optimistic outlook - Investing.com

Aug 16, 2024
pulisher
Aug 15, 2024

VolitionRX: Q2 Earnings Snapshot - San Antonio Express-News

Aug 15, 2024

VolitionRX Ltd (VNRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
大文字化:     |  ボリューム (24 時間):